Document is current
Any future updates will be listed below
-
Authors
Silvester, Jocelyn A. https://orcid.org/0000-0002-3615-1666
Graff, Lesley A.
Rigaux, Lisa
Bernstein, Charles N.
Leffler, Daniel A.
Kelly, Ciarán P.
Walker, John R.
Duerksen, Donald R.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK 07760)
Canadian Institutes of Health Research
Canadian Institutes of Health Research
Canadian Celiac Association
Canadian Association of Gastroenterology
Children's Hospital Research Institute of Manitoba
- License Information
-
More Information
Article History
Received: 22 March 2017
Accepted: 24 June 2017
First Online: 7 July 2017
Compliance with ethical standards
:
: DRD is on speaker’s bureau for Shire Canada. CNB is supported in part by the Bingham Chair in Gastroenterology. He has served on advisory boards of Abbvie Canada, Ferring Canada, Janssen Canada, Shire Canada, Takeda Canada, and Pfizer Canada and as a consultant to Mylan Pharmaceuticals. He has received educational grants from Shire Canada, Abbvie Canada, Takeda Canada, and Janssen Canada and is on the speaker’s bureau for Abbvie Canada, Ferring Canada and Shire Canada. CPK has worked as a consultant for Takeda Pharmaceuticals and Cour Pharmaceuticals. DAL is an employee of Takeda Pharmaceuticals. LAG, LR, JAS, JRW—nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
